Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Naiyer, Rizvi"'
Autor:
Ranee Mehra, Ina Rhee, Naiyer Rizvi, Robert L Ferris, Hussein Tawbi, Matthew D Hellmann, Sarah B Goldberg, Ryan J Sullivan, Helen X Chen, Jong Chul Park, Foluso O Ademuyiwa, Z Alexander Cao
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 3 (2023)
Although immunotherapy can offer profound clinical benefit for patients with a variety of difficult-to-treat cancers, many tumors either do not respond to upfront treatment with immune checkpoint inhibitors (ICIs) or progressive/recurrent disease occ
Externí odkaz:
https://doaj.org/article/fd73b0fbb8884f60901ba9db5264d2cd
Autor:
Mario Sznol, Naiyer Rizvi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 1 (2023)
Various approaches are being explored to address the unmet medical need among patients with advanced cancer who do not respond to immune checkpoint inhibitors. Interleukin-2 has become a prominent focus of preclinical and clinical investigation, beca
Externí odkaz:
https://doaj.org/article/a65296e3368d4716886c59a747826372
Autor:
Roy S Herbst, Naiyer Rizvi, Karen Kelly, Vassiliki A Papadimitrakopoulou, Natasha B Leighl, Mary W Redman, Fred R Hirsch, Philip C Mack, Lawrence H Schwartz, James L Wade, William J Irvin, Sreekanth C Reddy, Jeffrey Crawford, Jeffrey D Bradley, Thomas E Stinchcombe, Suresh S Ramalingam, Jieling Miao, Katherine Minichiello, David R Gandara
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 8 (2021)
Externí odkaz:
https://doaj.org/article/aa42cd2cdcbe45b39c93537b9fab9f89
Autor:
Arvind Ravi, Matthew D. Hellmann, Monica B. Arniella, Mark Holton, Samuel S. Freeman, Vivek Naranbhai, Chip Stewart, Ignaty Leshchiner, Jaegil Kim, Yo Akiyama, Aaron T. Griffin, Natalie I. Vokes, Mustafa Sakhi, Vashine Kamesan, Hira Rizvi, Biagio Ricciuti, Patrick M. Forde, Valsamo Anagnostou, Jonathan W. Riess, Don L. Gibbons, Nathan A. Pennell, Vamsidhar Velcheti, Subba R. Digumarthy, Mari Mino-Kenudson, Andrea Califano, John V. Heymach, Roy S. Herbst, Julie R. Brahmer, Kurt A. Schalper, Victor E. Velculescu, Brian S. Henick, Naiyer Rizvi, Pasi A. Jänne, Mark M. Awad, Andrew Chow, Benjamin D. Greenbaum, Marta Luksza, Alice T. Shaw, Jedd Wolchok, Nir Hacohen, Gad Getz, Justin F. Gainor
Publikováno v:
Nature Genetics. 55:807-819
Anti-PD-1/PD-L1 agents have transformed the treatment landscape of advanced non-small cell lung cancer (NSCLC). To expand our understanding of the molecular features underlying response to checkpoint inhibitors in NSCLC, we describe here the first jo
Autor:
Biagio Ricciuti, MD, Abdul Rafeh Naqash, MD, Jarushka Naidoo, MD, Kartik Sehgal, MD, Adam Miller, MD, Kenneth Kehl, MD, MPH, Deepti Venkatraman, MPH, Jacob Sands, MD, Giuseppe Lamberti, MD, Gonzalo Recondo, MD, PhD, Jiajia Zhang, MD, Shravanti Macherla, MD, Sameer Baig, MD, Paul Walker, MD, Deepa Rangachari, MD, Justin F. Gainor, MD, Daniel B. Costa, MD, Naiyer Rizvi, MD, Lynette M. Sholl, MD, Mizuki Nishino, MD, MPH, Brian Henick, MD, Anna F. Farago, MD, PhD, Mark M. Awad, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 1, Iss 4, Pp 100074- (2020)
Introduction: The development of immune-related adverse events (irAEs) has been associated with improved efficacy of immune checkpoint inhibitors in patients with urothelial cancer, melanoma, and NSCLC. Whether this association exists in patients wit
Externí odkaz:
https://doaj.org/article/44c33d5b25fc49e0a525d0f78bde07d6
Autor:
Marc Ladanyi, Raya Khanin, Naiyer Rizvi, Maureen F. Zakowski, Mark G. Kris, Valerie Rusch, Udayan Guha, Alexander Drilon, Yuki Kimura, Tatsuo Ito, Daphne Ang, Adnan Hasanovic, Lu Wang, Maria Arcila, Yoshiyuki Suehara
PDF file - 76K, Examples of negative results with the NanoString assay for kinase fusions.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b52325931782719f79c2f5aebafaf49
https://doi.org/10.1158/1078-0432.22451811.v1
https://doi.org/10.1158/1078-0432.22451811.v1
Autor:
Mohammed Dar, Dominic W. Lai, Jennifer McDevitt, Matthew Gribbin, Denison Kuruvilla, Thomas Kaley, Vicky Makker, Efrat Dotan, Lawrence Recht, Michael Birrer, Deborah K. Armstrong, Ronald Natale, Naiyer Rizvi, David M. Hyman
SUPPLEMENTARY TABLES Supplementary Table 1. Treatment-emergent grade 3/4 adverse events in the safety population (n=116) Supplementary Table 2. MEDI3617 pharmacokinetic parameters Supplementary Table 3. Treatment outcome: objective response and progr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35b73097687608e3f3c7d778debbbc10
https://doi.org/10.1158/1078-0432.22465569.v1
https://doi.org/10.1158/1078-0432.22465569.v1
Autor:
Jordan Berlin, Darrin Beaupre, Robert A. Beckman, Abdel-Baset Halim, Agnes Ang, Chi-Yuan Wu, Thore Hettmann, Catherine Copigneaux, Lorrin Yee, Vicki Keedy, Lisa Malburg, Naiyer Rizvi, Moacyr Oliveira, Pasi A. Jänne, Patricia LoRusso
PDF - 278K, Supplementary Methods and Materials, QTc prolongation results. Supplementary Figure 1 - QTc prolongation compared with serum U3-1287 concentration. Supplementary Figure 2 - U3-1287-mediated pancreatic xenograft growth inhibition)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8088012567f918b89bc000dffe8b6149
https://doi.org/10.1158/1078-0432.22451111
https://doi.org/10.1158/1078-0432.22451111
Autor:
Marc Ladanyi, Raya Khanin, Naiyer Rizvi, Maureen F. Zakowski, Mark G. Kris, Valerie Rusch, Udayan Guha, Alexander Drilon, Yuki Kimura, Tatsuo Ito, Daphne Ang, Adnan Hasanovic, Lu Wang, Maria Arcila, Yoshiyuki Suehara
PDF file - 308K, Complete list of target sequences for NanoString probes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a8736d7e24f4238da3f69aba0500b02
https://doi.org/10.1158/1078-0432.22451805.v1
https://doi.org/10.1158/1078-0432.22451805.v1
Autor:
Marc Ladanyi, Raya Khanin, Naiyer Rizvi, Maureen F. Zakowski, Mark G. Kris, Valerie Rusch, Udayan Guha, Alexander Drilon, Yuki Kimura, Tatsuo Ito, Daphne Ang, Adnan Hasanovic, Lu Wang, Maria Arcila, Yoshiyuki Suehara
Background: The mutually exclusive pattern of the major driver oncogenes in lung cancer suggests that other mutually exclusive oncogenes exist. We conducted a systematic search for tyrosine kinase fusions by screening all tyrosine kinases for aberran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6181f29fc7c6a723807168adc85cc721
https://doi.org/10.1158/1078-0432.c.6522300.v1
https://doi.org/10.1158/1078-0432.c.6522300.v1